Spots Global Cancer Trial Database for endometrium cancer
Every month we try and update this database with for endometrium cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Weight Management in Overweight Endometrial Cancer Patients Undergoing Fertility-sparing Treatment | NCT06169449 | Endometrium Can... | Weight manageme... Weight manageme... Weight manageme... Weight manageme... Control group | 18 Years - | Peking University People's Hospital | |
| Pembrolizumab With Ataluren in Patients With Metastatic pMMR and dMMR Colorectal Carcinoma or Metastatic dMMR Endometrial Carcinoma: the ATAPEMBRO Study | NCT04014530 | Colorectal Canc... Endometrium Can... | Ataluren + Pemb... | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | |
| Safety of BKM120 Monotherapy in Advanced Solid Tumor Patients | NCT01068483 | Breast Cancer Colon Cancer Ovarian Cancer Endometrium Can... | BKM120 | 18 Years - | Novartis | |
| Pembrolizumab With Ataluren in Patients With Metastatic pMMR and dMMR Colorectal Carcinoma or Metastatic dMMR Endometrial Carcinoma: the ATAPEMBRO Study | NCT04014530 | Colorectal Canc... Endometrium Can... | Ataluren + Pemb... | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | |
| The Effect of Logotherapy on Mental Health in Gynecological Cancer Patients | NCT05246462 | Cancer of Ovary Endometrium Can... Cervix Cancer | Logotherapy | 18 Years - | Akdeniz University | |
| Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors | NCT02552121 | Ovary Cancer Cervix Cancer Endometrium Can... Bladder Cancer Prostate Cancer... Esophagus Cance... Lung Cancer (NS... | Tisotumab vedot... | 18 Years - | Seagen Inc. | |
| A Study of PF-07260437 in Advanced or Metastatic Solid Tumors | NCT05067972 | Ovarian Neoplas... Endometrial Neo... Breast Neoplasm... | PF-07260437 B7-H4 IHC | 18 Years - | Pfizer | |
| Apoptotic Signaling Pathways in Rats With Endometrial Hyperplasia | NCT02872818 | Apoptotic Signa... | 17β estradiol h... Metformin medroxyprogeste... | 8 Weeks - 10 Weeks | Kayseri Education and Research Hospital | |
| Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers | NCT04464967 | Advanced Solid ... Metastatic Canc... HER2-positive B... HER2-positive G... HER-2 Protein O... Esophageal Canc... Ovarian Cancer Endometrium Can... Bladder Cancer Pancreatic Canc... Colorectal Canc... Non Small Cell ... EGF-R Positive ... Head and Neck S... Triple Negative... Cervical Cancer Sarcoma | SNK01 Trastuzumab Cetuximab | 18 Years - 75 Years | NKGen Biotech, Inc. | |
| Application of Thrombin Gel Matrix for the Prevention of Lymphocele in Patients With Endometrial Cancer. | NCT04205864 | Lymphocele Lymphocele Afte... Endometrium Can... | Thrombi-Gel Conventional Pe... | 18 Years - 90 Years | Kocaeli University | |
| Effect of Physical Activity Intervention on Overweight and Obese Patients With Endometrial Cancer | NCT06312917 | Endometrium Can... Physical Activi... Weight Manageme... | Physical activi... | 20 Years - 40 Years | Peking University People's Hospital | |
| Weight Management in Overweight Endometrial Cancer Patients Undergoing Fertility-sparing Treatment | NCT06169449 | Endometrium Can... | Weight manageme... Weight manageme... Weight manageme... Weight manageme... Control group | 18 Years - | Peking University People's Hospital | |
| Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery | NCT02997553 | Breast Carcinom... Head and Neck C... Melanoma (Skin) Squamous Cell C... Cervix Cancer Endometrium Can... Ovary Cancer Vulva Cancer Anus Cancer Rectum Cancer | Indocyanine gre... Technetium99 Optonuclear pro... Quest Camera | 18 Years - | Institut de Cancérologie de Lorraine | |
| Safety of BKM120 Monotherapy in Advanced Solid Tumor Patients | NCT01068483 | Breast Cancer Colon Cancer Ovarian Cancer Endometrium Can... | BKM120 | 18 Years - | Novartis | |
| A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma | NCT05036681 | Metastatic Canc... Endometrium Can... Endometrial Car... | Futibatinib Pembrolizumab | 18 Years - | M.D. Anderson Cancer Center | |
| Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors | NCT02001623 | Ovary Cancer Cervix Cancer Endometrium Can... Bladder Cancer Prostate Cancer... Esophagus Cance... Lung Cancer(NSC... Squamous Cell C... | Tisotumab Vedot... | 18 Years - | Seagen Inc. | |
| Neoadjuvant Celecoxib in Newly Diagnosed Patients With Endometrial Carcinoma | NCT03896113 | Endometrium Can... | Celecoxib 200mg... | 18 Years - 99 Years | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | |
| Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors | NCT02001623 | Ovary Cancer Cervix Cancer Endometrium Can... Bladder Cancer Prostate Cancer... Esophagus Cance... Lung Cancer(NSC... Squamous Cell C... | Tisotumab Vedot... | 18 Years - | Seagen Inc. | |
| Suspension of the Pelvic and Abdominal Organs During Minimally Invasive Surgery | NCT06187558 | Endometriosis Pelvic Prolapse Endometrium Can... | Pelvic and abdo... | - | University of Cagliari | |
| A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma | NCT05036681 | Metastatic Canc... Endometrium Can... Endometrial Car... | Futibatinib Pembrolizumab | 18 Years - | M.D. Anderson Cancer Center | |
| Effect of a Lifestyle Intervention on Nutritional Status and Prognosis of Endometrial Cancer Survivors | NCT03095664 | Endometrium Can... Life Style Obesity | Intervention gr... | 20 Years - 69 Years | Brazilian National Cancer Institute | |
| Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors. | NCT03245736 | Ovary Cancer Cervix Cancer Endometrium Can... Bladder Cancer Prostate Cancer Esophagus Cance... Lung Cancer, No... Squamous Cell C... | Tisotumab Vedot... | 18 Years - | Seagen Inc. | |
| A Trial for Patients With Advanced/Recurrent Endometrial Cancer | NCT00377520 | Neoplasms Neoplasms by Si... Urogenital Neop... Genital Neoplas... Uterine Neoplas... Endometrial Neo... Cancer of Endom... Endometrial Can... Cancer of the E... Endometrium Can... Neoplasms, Endo... | pemetrexed | - | Eli Lilly and Company | |
| Investigating the Use of Fluorescence Imaging in Endometrial Cancer Surgery | NCT01562106 | Endometrial Can... | Fluorescence-gu... | 18 Years - | Swedish Medical Center | |
| ROGYcare: The Impact of a Cancer Survivorship Care Plan on Patient Reported Outcomes and Health Care Providers | NCT01185626 | Ovarian Cancer Endometrium Can... | SCP care | 18 Years - | Tilburg University | |
| Endometrial Cancer and Robotic-assisted Versus Traditional Laparoscopy | NCT01466777 | Endometrium Can... | Traditional sur... Robotic assiste... | 30 Years - 85 Years | Tampere University Hospital | |
| Suspension of the Pelvic and Abdominal Organs During Minimally Invasive Surgery | NCT06187558 | Endometriosis Pelvic Prolapse Endometrium Can... | Pelvic and abdo... | - | University of Cagliari | |
| Probe-based and Needle-based Confocal Laser Endomicroscopy During Gynaecological Procedures. | NCT02221076 | Cervix Cancer Endometrium Can... Ovarian Cancer Carcinoma in Si... | Confocal Laser ... | 18 Years - | Mauna Kea Technologies | |
| Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors. | NCT03245736 | Ovary Cancer Cervix Cancer Endometrium Can... Bladder Cancer Prostate Cancer Esophagus Cance... Lung Cancer, No... Squamous Cell C... | Tisotumab Vedot... | 18 Years - | Seagen Inc. | |
| Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers | NCT04464967 | Advanced Solid ... Metastatic Canc... HER2-positive B... HER2-positive G... HER-2 Protein O... Esophageal Canc... Ovarian Cancer Endometrium Can... Bladder Cancer Pancreatic Canc... Colorectal Canc... Non Small Cell ... EGF-R Positive ... Head and Neck S... Triple Negative... Cervical Cancer Sarcoma | SNK01 Trastuzumab Cetuximab | 18 Years - 75 Years | NKGen Biotech, Inc. | |
| Investigating the Use of Fluorescence Imaging in Endometrial Cancer Surgery | NCT01562106 | Endometrial Can... | Fluorescence-gu... | 18 Years - | Swedish Medical Center | |
| Neoadjuvant Celecoxib in Newly Diagnosed Patients With Endometrial Carcinoma | NCT03896113 | Endometrium Can... | Celecoxib 200mg... | 18 Years - 99 Years | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | |
| Risk Evaluation and Screening to Tailor Prevention and Reduce the Incidence of Endometrial Cancer | NCT05651282 | Endometrium Can... | Provera | - | University of British Columbia | |
| Cryotherapy vs. Cryocompression for Preventing Chemotherapy-induced-peripheral-neuropathy in Women Undergoing Chemotherapy | NCT04632797 | Chemotherapy-in... Chemotherapeuti... Chemotherapeuti... | Hilotherm Chemo... | 18 Years - 99 Years | Medical University Innsbruck | |
| PET/CT in the Management of Patients With Early Stage Endometrial Cancer | NCT03570866 | Endometrium Can... | Positron emissi... Surgical treatm... | - | Università degli Studi dell'Insubria | |
| A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma | NCT05036681 | Metastatic Canc... Endometrium Can... Endometrial Car... | Futibatinib Pembrolizumab | 18 Years - | M.D. Anderson Cancer Center | |
| Pembrolizumab With Ataluren in Patients With Metastatic pMMR and dMMR Colorectal Carcinoma or Metastatic dMMR Endometrial Carcinoma: the ATAPEMBRO Study | NCT04014530 | Colorectal Canc... Endometrium Can... | Ataluren + Pemb... | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | |
| Relationship of Endometrial Cancer and Serum Soluble L1CAM Level | NCT04603599 | Endometrium Can... | serum soluble L... | 18 Years - | Kocaeli University | |
| A Study of PF-07260437 in Advanced or Metastatic Solid Tumors | NCT05067972 | Ovarian Neoplas... Endometrial Neo... Breast Neoplasm... | PF-07260437 B7-H4 IHC | 18 Years - | Pfizer | |
| Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers | NCT04464967 | Advanced Solid ... Metastatic Canc... HER2-positive B... HER2-positive G... HER-2 Protein O... Esophageal Canc... Ovarian Cancer Endometrium Can... Bladder Cancer Pancreatic Canc... Colorectal Canc... Non Small Cell ... EGF-R Positive ... Head and Neck S... Triple Negative... Cervical Cancer Sarcoma | SNK01 Trastuzumab Cetuximab | 18 Years - 75 Years | NKGen Biotech, Inc. | |
| A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer | NCT05902988 | Advanced Solid ... High Grade Sero... Squamous Non-sm... Triple Negative... Gastric Adenoca... Colorectal Aden... Esophageal Squa... Esophageal Aden... Gastroesophagea... Transitional Ce... Head and Neck S... Ovarian Carcino... Uterine Carcino... Uterine Serous ... Endometrium Can... Chromosomal Ins... | VLS-1488 | 18 Years - | Volastra Therapeutics, Inc. | |
| The Effect of Logotherapy on Mental Health in Gynecological Cancer Patients | NCT05246462 | Cancer of Ovary Endometrium Can... Cervix Cancer | Logotherapy | 18 Years - | Akdeniz University | |
| Durvalumab and Olaparib in Metastatic or Recurrent Endometrial Cancer | NCT03951415 | Endometrial Neo... Uterine Neoplas... Endometrium Can... | PARP inhibitor ... | 18 Years - | Leiden University Medical Center | |
| Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery | NCT02997553 | Breast Carcinom... Head and Neck C... Melanoma (Skin) Squamous Cell C... Cervix Cancer Endometrium Can... Ovary Cancer Vulva Cancer Anus Cancer Rectum Cancer | Indocyanine gre... Technetium99 Optonuclear pro... Quest Camera | 18 Years - | Institut de Cancérologie de Lorraine | |
| Safety and Efficacy of Retifanlimab (INCMGA00012) Alone or in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-based Chemotherapy. | NCT04463771 | Endometrial Can... | retifanlimab epacadostat pemigatinib INCAGN02385 INCAGN02390 | 18 Years - | Incyte Corporation | |
| Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer | NCT04269200 | Endometrial Neo... | olaparib durvalumab durvalumab plac... olaparib placeb... Carboplatin Paclitaxel | 18 Years - 150 Years | AstraZeneca | |
| Suspension of the Pelvic and Abdominal Organs During Minimally Invasive Surgery | NCT06187558 | Endometriosis Pelvic Prolapse Endometrium Can... | Pelvic and abdo... | - | University of Cagliari |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
